Precision medicine–tailoring drug treatment
to specific patient populations–holds enormous potential for the future of healthcare. Here at PBA, we conduct phenotypic drug discovery and development using patient-derived disease models and AI to advance treatments for targeted patient populations.

We believe that precision medicine can address the complexities of disease and biological interactions on the whole-genome level.